Atsushi Enomoto Selected Research

Chronic Renal Insufficiency

5/2014	Indoxyl sulfate-induced activation of (pro)renin receptor is involved in expression of TGF-β1 and α-smooth muscle actin in proximal tubular cells.
1/2010	Indoxyl sulfate upregulates expression of ICAM-1 and MCP-1 by oxidative stress-induced NF-kappaB activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Atsushi Enomoto Research Topics

Disease

50	Neoplasms (Cancer) 03/2024 - 08/2004
10	Fibrosis (Cirrhosis) 03/2024 - 11/2010
5	Neoplasm Metastasis (Metastasis) 01/2024 - 03/2008
5	Chronic Kidney Failure (Chronic Renal Failure) 11/2011 - 03/2003
5	Neuroblastoma 06/2011 - 08/2006
5	Renal hypouricemia 06/2005 - 09/2003
4	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2024 - 07/2018
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2022 - 10/2012
4	Glioma (Gliomas) 01/2019 - 10/2004
4	Schizophrenia (Dementia Praecox) 08/2015 - 09/2009
3	Hyperthermia 01/2024 - 10/2004
3	Carcinogenesis 01/2023 - 04/2009
3	Breast Neoplasms (Breast Cancer) 10/2022 - 03/2008
3	Pancreatic Neoplasms (Pancreatic Cancer) 03/2022 - 01/2018
3	Cardiovascular Diseases (Cardiovascular Disease) 11/2019 - 09/2003
3	Leukemia 01/2017 - 10/2003
3	Endometrial Neoplasms (Endometrial Cancer) 07/2015 - 10/2009
2	Pruritus (Itching) 05/2024 - 06/2022
2	Non-alcoholic Fatty Liver Disease 12/2023 - 08/2021
2	Hemorrhage 11/2023 - 01/2023
2	Inflammation (Inflammations) 01/2023 - 07/2018
2	Obesity 01/2023 - 12/2018
2	Disease Progression 08/2022 - 02/2022
2	Autoimmune Diseases (Autoimmune Disease) 07/2022 - 12/2021
2	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 10/2012
2	Fibroma (Fibromatosis) 01/2022 - 06/2016
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 08/2004
2	Lung Neoplasms (Lung Cancer) 12/2020 - 03/2013
2	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 01/2017
2	Myocardial Infarction 01/2019 - 11/2015
2	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 03/2018 - 01/2018
2	Lymphatic Metastasis 02/2016 - 03/2013
2	Vascular Remodeling 08/2014 - 05/2011
2	Chronic Renal Insufficiency 05/2014 - 01/2010
2	Ataxia Telangiectasia (Louis Bar Syndrome) 09/2012 - 10/2004
2	Diabetic Nephropathies (Diabetic Nephropathy) 06/2011 - 03/2003
2	Kidney Diseases (Kidney Disease) 06/2011 - 07/2006
2	Gout 06/2005 - 09/2003
2	Hyperuricemia 06/2005 - 09/2003
1	Osteosarcoma (Osteogenic Sarcoma) 01/2024
1	Fatty Liver 12/2023
1	Body Weight (Weight, Body) 01/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023
1	Psoriatic Arthritis 01/2023

Drug/Important Bio-Agent (IBA)

26	Proteins (Proteins, Gene)FDA Link 03/2022 - 08/2004
10	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 05/2023 - 10/2012
7	IndicanIBA 05/2014 - 03/2003
6	CollagenIBA 03/2024 - 11/2015
6	Glycoproteins (Glycoprotein)IBA 05/2023 - 10/2012
6	Microfilament Proteins (Actin Binding Proteins)IBA 11/2020 - 03/2008
6	DNA (Deoxyribonucleic Acid)IBA 03/2014 - 08/2004
6	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 06/2011 - 07/2005
5	Small Interfering RNA (siRNA)IBA 01/2018 - 08/2006
4	CytokinesIBA 05/2024 - 12/2021
4	AntibodiesIBA 01/2024 - 05/2008
4	Collagen Type I (Type I Collagen)IBA 07/2022 - 07/2018
4	Uric Acid (Urate)IBA 06/2005 - 09/2003
3	Indicators and Reagents (Reagents)IBA 01/2023 - 11/2021
3	Transforming Growth Factors (Transforming Growth Factor)IBA 04/2022 - 03/2013
3	RNA (Ribonucleic Acid)IBA 12/2021 - 03/2008
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 03/2014
3	IntegrinsIBA 05/2014 - 10/2009
3	AST 120IBA 05/2014 - 03/2003
3	Uremic ToxinsIBA 11/2010 - 07/2002
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2010 - 07/2005
3	urate transporterIBA 02/2004 - 09/2003
2	apremilastIBA 05/2024 - 05/2024
2	Phosphotransferases (Kinase)IBA 01/2024 - 10/2004
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 11/2022 - 01/2021
2	Silicon Dioxide (Silica)FDA LinkGeneric 10/2022 - 01/2021
2	human ERBB2 proteinIBA 10/2022 - 05/2008
2	tamibaroteneIBA 02/2022 - 01/2022
2	AutoantigensIBA 12/2021 - 03/2018
2	Temozolomide (Temodar)FDA LinkGeneric 01/2019 - 12/2017
2	Serine (L-Serine)FDA Link 11/2015 - 05/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2015 - 02/2013
2	Cisplatin (Platino)FDA LinkGeneric 05/2014 - 04/2009
2	Complementary DNA (cDNA)IBA 03/2013 - 02/2004
2	DNA-Activated Protein KinaseIBA 09/2012 - 08/2004
2	GalactosidasesIBA 11/2011 - 11/2010
2	ParaffinIBA 10/2009 - 05/2008
2	Formaldehyde (Formol)FDA Link 10/2009 - 05/2008
2	CreatinineIBA 07/2006 - 01/2004
2	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 10/2004 - 08/2004
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2024
1	Interleukin-8 (Interleukin 8)IBA 01/2024
1	MAP Kinase Kinase 4IBA 01/2024
1	elobixibatIBA 12/2023
1	Bile Acids and Salts (Bile Acids)IBA 12/2023
1	taxifolinIBA 01/2023
1	fibroblast growth factor 21IBA 01/2023
1	Interleukin-17 (Interleukin 17)IBA 01/2023
1	Interleukin-23 (Interleukin 23)IBA 01/2023
1	tildrakizumabIBA 01/2023
1	Tyrosine (L-Tyrosine)FDA Link 11/2022
1	Trastuzumab (Herceptin)FDA Link 10/2022

Therapy/Procedure

16	Therapeutics 01/2023 - 10/2004
4	Drug Therapy (Chemotherapy) 01/2024 - 10/2012
2	Radiotherapy 11/2021 - 07/2015
1	Precision Medicine 01/2023